Marinke Moeliker

I mainly assist international clients in a wide range of corporate transactions including cross-border mergers and acquisitions, joint ventures and minority investments, with a particular focus on corporate transactions in the life sciences and tech & communication sectors. In addition, I regularly advise tech start ups on a wide variety of corporate-related matters.

I enjoy working closely with my colleagues in different practice areas both in the Netherlands and in our other offices around the world, to offer our clients seamless cross-jurisdictional advice and a one-stop-shop approach covering all legal aspects of complex cross-border transactions. We provide expertise in due diligence and risk assessment exercises, as well as in transitional services agreements and technology separation arrangements in support of the implementation of corporate deals.

• Assisting a main independent infrastructure operator for wireless telecommunication in Europe headquartered in Spain, on the acquisition of a large number of telephony sites in the Netherlands.
• Assisting a public company listed on the TSX Venture Exchange in Canada, known as preeminent supplier of custom antibodies to the global research industry and industrial community, on the acquisition of several businesses active in the same field in the Netherlands.
• Assisting a leading IoT security company listed on Nasdaq in connection with the acquisition of a global leader based in the Netherlands in operational technology (OT) and industrial control systems (ICS) network assessment and protection.
• Assisting a UK-based leading technology-based provider of communication services listed on LSE on the acquisition of a Dutch telecoms group focused on offering cloud PBX solutions, SIP trunks, data products and mobile services.
• Assisting Belgium's leading telecommunication and ICT company on the acquisition of a managed service provider based in the Netherlands and of businesses active in the field of machine data analysis and IT service management processes.

• Corporate